Seda return to Boston for 6th TPD Summit
Seda are a UK based CRO supporting formulation development with integrated pharmaceutical development and clinical pharmacology expertise, using PK modelling to guide real time decision making.
Location, Boston– 30th October 2023 Linette Ruston and Jake Dickinson from Seda’s PK modelling team, are delighted to be visiting Boston for 6th TPD Summit. This trip follows a successful Bio Boston trip back in June by Seda Directors Paul Stott, Paul Dickinson & Marcel de Matas.
The 6th Targeted Protein Degradation Summit speaker schedule on novel approaches to accessing “undruggable” targets, was the key draw for Linette and Jake.
“At Seda we’re keen to stay informed to remain ahead of the curve in terms of advances and developments driving the next generation of degradation and stabilisation approaches such as PROTACs and molecular glue, that will revolutionise breakthrough drug development in the treatment areas of oncology and CNS. We’re really looking forward to the insightful speaker sessions as well as using our Boston presence to network with new contacts and further cement existing relationships” – Linette Ruston
Jake and Linette invite MassBio members to get in touch to arrange meetings with them during their trip between 30th October and 2nd November.
linkedin.com/in/jake-dickinson-680376100
linkedin.com/in/linette-ruston-b7b908b
For more information on Seda’s services:
https://www.sedapds.com/
Paula Goddard.
Paula.Goddard@sedapds.com